Perhexiline
Perhexiline is an orally active CPT1 and CPT2 inhibitor that reduces fatty acid metabolism. Perhexiline induces mitochondrial dysfunction and apoptosis in hepatic cells. Perhexiline can cross the blood brain barrier (BBB) and shows anti-tumor activity. Perhexiline can be used in the research of cancers, and cardiovascular disease like angina[1][2][5].
Product Specifications
CAS Number
6621-47-2
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
Apoptosis; Mitochondrial Metabolism
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/perhexiline.html
Purity
99.93
Solubility
DMSO : ≥ 100 mg/mL
Smiles
C1(CC(C2CCCCC2)C3CCCCC3)NCCCC1
Molecular Formula
C19H35N
Molecular Weight
277.49
Precautions
H315, H319, H320
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal PDE9A Antibody [FITC]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
LSM1, CT (U6 snRNA-associated Sm-like Protein LSm1, Cancer-associated Sm-like, Small Nuclear Ribonuclear CaSm, CASM) (HRP) discontinued